Amgen Acquiring BioVex For $1 Billion
Amit Chowdhry | January 26, 2011 | 532 views | Add a CommentCategorized under Amgen, BioVex Group, OncoVex

Amgen, a human therapeutics company that focuses on advances in recombinant DNA will be acquiring BioVex Group for $1 billion. BioVex is a biotechnology company that works on the treatment of cancer.
